NEW YORK (GenomeWeb) – Supporting continued marketing of its breast cancer subtyping test MammaTyper, German MDx firm BioNTech Diagnostics published a study last month comparing the test for the first time with both visual and computer-assisted immunohistochemistry methods.
Get the full story with
GenomeWeb Premium Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Be the first to comment